Literature DB >> 20567010

Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors.

Vivek Subbiah, Jonathan C Trent, Razelle Kurzrock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567010     DOI: 10.1200/JCO.2010.29.4678

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

Review 1.  Molecular profiling of sarcomas: new vistas for precision medicine.

Authors:  Tariq Al-Zaid; Wei-Lien Wang; Neeta Somaiah; Alexander J Lazar
Journal:  Virchows Arch       Date:  2017-06-29       Impact factor: 4.064

2.  The physiology and pathophysiology of rapamycin resistance: implications for cancer.

Authors:  Philip A Gruppuso; Joan M Boylan; Jennifer A Sanders
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

3.  PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.

Authors:  Wolfgang Scheppach; Nikolaus Reissmann; Thomas Sprinz; Ekkehard Schippers; Bjoern Schoettker; Justus G Mueller
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

4.  Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.

Authors:  Mark A Dickson; Gary K Schwartz; Cristina R Antonescu; David J Kwiatkowski; Izabela A Malinowska
Journal:  Int J Cancer       Date:  2012-09-21       Impact factor: 7.396

5.  A patient presenting with a perivascular epithelioid cell tumor in the broad ligament: a case report.

Authors:  Claire Ross; Sunita Sharma; Onsy Louca; Michelle Scurr; Andrew Hayes; Ian Judson
Journal:  J Med Case Rep       Date:  2011-08-16

6.  Malignant perivascular epithelioid cell tumor of the uterus.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Rare Tumors       Date:  2012-03-12

7.  Targeted therapies in sarcomas: challenging the challenge.

Authors:  Juan Martín Liberal; Laura Lagares-Tena; Miguel Sáinz-Jaspeado; Silvia Mateo-Lozano; Xavier García Del Muro; Oscar M Tirado
Journal:  Sarcoma       Date:  2012-06-03

8.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26

9.  A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma.

Authors:  Vivek Subbiah; Robert E Brown; Mary F McGuire; Jamie Buryanek; Filip Janku; Anas Younes; David Hong
Journal:  Oncotarget       Date:  2014-01-15

10.  Perivascular Epithelioid Cell Tumor of the Buttock Region.

Authors:  Rafey Rehman; Mariam Aoun; Ronald Levitin; Thomas Quinn; Peyman Kabolizadeh
Journal:  Cureus       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.